Detection and analysis of human papillomavirus (HPV) DNA in breast cancer patients by an effective method of HPV capture

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wang, Ting ^a   Zeng, Xi ^b,d   Li, Weiyang ^b,c   Zhu, Haijun ^a   Wang, Guan ^b   Liu, Xiao ^b,e   Lv, Yonggang ^a   Wu, Jinghua ^b   Zhuang, Xuehan ^b   Zhang, Juliang ^a   Zhao, Yi ^b,c   Huang, Haodong ^b,c   Fan, Jing ^a   Yao, Qing ^a   He, Chenyang ^a   Zhang, Xiuqing ^b   Huang, Chen ^a   Chen, Jianghao ^a   Wang, Ling ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BGI SHENZHEN   (China)

^c SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E2; VIRUS DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; E2 GENE; E4 GENE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MASSIVE PARALLELED SEQUENCING; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VERY ELDERLY; VIRUS DETECTION; VIRUS GENE; VIRUS IDENTIFICATION; BREAST TUMOR; GENETICS; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, VIRAL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 84897546330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090343     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
2. Campeau PM, Foulkes WD, Tischkowitz MD (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124: 31-42.
3. Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15: 617-631.
4. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044.
5. Antonsson A, Bialasiewicz S, Rockett RJ, Jacob K, Bennett IC, et al. (2012) Exploring the prevalence of ten polyomaviruses and two herpes viruses in breast cancer. PLoS One 7: e39842.
6. Silva RG Jr, da Silva BB (2011) No evidence for an association of human papillomavirus and breast carcinoma. Breast Cancer Res Treat 125: 261-264.
7. zur Hausen H (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384: 260-265.
8. Acevedo-Nuno E, Gonzalez-Ojeda A, Vazquez-Camacho G, Balderas-Pena Luz Ma A, Moreno-Villa H, et al. (2004) Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett's oesophagus and oesophagitis. Anticancer Res 24: 1319-1323. (Pubitemid 38624982)
9. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, et al (2010) A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70:3159-3169.
10. Gheit T, Cornet I, Clifford GM, Iftner T, Munk C, et al. (2011) Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol Biomarkers Prev 20: 1315-1321.
11. Di Lonardo A, Venuti A, Marcante ML (1992) Human papillomavirus in breast cancer. Breast Cancer Res Treat 21: 95-100.
12. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE (2005) Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 7: R1-11.
13. Damin AP, Karam R, Zettler CG, Caleffi M, Alexandre CO (2004) Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 84: 131-137. (Pubitemid 38393363)
14. Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES (2006) Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 39: 727-731. (Pubitemid 44036781)
15. Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, et al. (2006) HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res 25: 515-521. (Pubitemid 46166765)
16. Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G (2007) Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 16: 172-177. (Pubitemid 46488811)
17. de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, et al. (2008) No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 109: 55-58. (Pubitemid 351538756)
18. Wrede D, Luqmani YA, Coombes RC, Vousden KH (1992) Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer 65: 891-894.
19. Li R, Yu C, Li Y, Lam TW, Yiu SM, et al. (2009) SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 25: 1966-1967.
20. Li R, Li Y, Fang X, Yang H, Wang J, et al. (2009) SNP detection for massively parallel whole-genome resequencing. Genome Res 19: 1124-1132.
21. Li W, Zeng X, Lee NP, Liu X, Chen S, et al. (2013) HIVID: An efficient method to detect HBV integration using low coverage sequencing. Genomics 102: 338-344.
22. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720. (Pubitemid 30365531)
23. Chen AC, Keleher A, Kedda MA, Spurdle AB, McMillan NA, et al. (2009) Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol 81: 1792-1796.
24. Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C (2004) Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 31: 292-297. (Pubitemid 39371063)
25. Masterson PJ, Stanley MA, Lewis AP, Romanos MA (1998) A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J Virol 72: 7407-7419;
26. Blakaj DM, Fernandez-Fuentes N, Chen Z, Hegde R, Fiser A, et al. (2009) Evolutionary and biophysical relationships among the papillomavirus E2 proteins. Front Biosci 14: 900-917.
27. Shang Q, Wang Y, Fang Y, Wei L, Chen S, et al(2011) Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Identification of Cervical Carcinomas in Patients in Northeast China, JOURNAL OFCLINICALMICROBIOLOGY, 49:2656-2663;
28. Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, et al(2011) Sequence Imputation of HPV16 Genomes for Genetic Association Studies,Plos one 6:e21375.
29. Liu X, Liu GB, Pang ZJ, Xing FQ (2005) Sequence polymorphism of human papillomavirus type 16 E7 in cervical cancer]. Di Yi Jun Yi Da Xue Xue Bao 25: 1272-1275.
30. Kimura M (1977) Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 267: 275-276.
31. Miyata T, Miyazawa S, Yasunaga T (1979) Two types of amino acid substitutions in protein evolution. J Mol Evol 12: 219-236. (Pubitemid 9134468)
32. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, et al. (2008) Arrangement of L2 within the Papillomavirus Capsid. J Virol 82: 5190-5197 (Pubitemid 351705228)
33. Sun M, Gao L, Liu Y, Zhao Y, Wang X, et al(2012) Whole Genome Sequencing and Evolutionary Analysis of Human Papillomavirus Type 16 in Central China. PLoS ONE 7(5): e36577
34. Wang T, Chang P, Wang L, Yao Q, Guo W, et al. (2012) The role of human papillomavirus infection in breast cancer. Med Oncol 29: 48-55.